Publicacións en colaboración con investigadores/as de Instituto de Salud Carlos III (4)

2023

  1. Cognitive Function with PCSK9 Inhibitors: A 24-Month Follow-Up Observational Prospective Study in the Real World—MEMOGAL Study

    American Journal of Cardiovascular Drugs, Vol. 23, Núm. 5, pp. 583-593

2022

  1. Impact of the COVID-19 pandemic in the lipid control of the patients that start PCSK9 inhibitors

    Clinica e Investigacion en Arteriosclerosis, Vol. 34, Núm. 5, pp. 245-252

2019

  1. The Spanish Network of Agencies for Health Technology Assessment and Services of the National Health System (RedETS)

    International Journal of Technology Assessment in Health Care, Vol. 35, Núm. 3, pp. 176-180

2018

  1. Melanin-Concentrating Hormone acts through hypothalamic kappa opioid system and p70S6K to stimulate acute food intake

    Neuropharmacology, Vol. 130, pp. 62-70